{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T01:01:16Z","timestamp":1708045276821},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.atherosclerosis.2010.01.004","type":"journal-article","created":{"date-parts":[[2010,1,12]],"date-time":"2010-01-12T10:00:28Z","timestamp":1263290428000},"page":"637-642","source":"Crossref","is-referenced-by-count":10,"title":["Is inflammation prior to renal transplantation predictive for cardiovascular and renal outcomes?"],"prefix":"10.1016","volume":"210","author":[{"given":"Bernd","family":"Kr\u00fcger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Walberer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Debler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten A.","family":"B\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan W.","family":"Reinhold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiman","family":"Obed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J\u00fcrgen","family":"Schlitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fischereder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Banas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard K.","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib1","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2215\/CJN.00930209","article-title":"Inflammation in renal transplantation","volume":"4","author":"Abedini","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1523-1755.2004.00751.x","article-title":"Predicting coronary heart disease in renal transplant recipients: a prospective study","volume":"66","author":"Ducloux","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib3","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/01.TP.0000121194.20339.0A","article-title":"Serologic evidence of Chlamydia pneumoniae infection as a long-term predictor of cardiovascular death in renal transplant recipients","volume":"77","author":"Haubitz","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1432-2277.2007.00626.x","article-title":"No effect of C-reactive protein (CRP) haplotypes on CRP levels and post-transplant morbidity and mortality in renal transplantation","volume":"21","author":"Kr\u00fcger","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.ajkd.2003.11.011","article-title":"Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients","volume":"43","author":"Varagunam","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib6","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1600-6143.2004.00477.x","article-title":"C-reactive protein and body mass index independently predict mortality in kidney transplant recipients","volume":"4","author":"Winkelmayer","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cardiores.2006.03.004","article-title":"C-reactive protein in atherosclerosis: a causal factor?","volume":"71","author":"Paffen","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib8","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1096\/fj.00-0468fje","article-title":"The terminal complement complex C5b-9 stimulates interleukin-6 production in human smooth muscle cells through activation of transcription factors NF-kappa B and AP-1","volume":"14","author":"Viedt","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib9","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.4049\/jimmunol.165.2.1030","article-title":"Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component","volume":"165","author":"Szalai","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1527-3466.2006.00033.x","article-title":"C-reactive protein (CRP)-lowering agents","volume":"24","author":"Prasad","year":"2006","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib11","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(09)60447-5","article-title":"Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial","volume":"373","author":"Ridker","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1523-1755.2005.00396.x","article-title":"C-reactive protein as predictor of death in end-stage diabetic nephropathy: role of peripheral arterial disease","volume":"68","author":"B\u00f6ger","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfm381","article-title":"Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients\u2014no additional power for mortality prediction with high-sensitivity CRP","author":"Grootendorst","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1523-1755.61.s80.18.x","article-title":"Inflammation and cardiovascular risk in dialysis patients","author":"Wanner","year":"2002","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib15","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1681\/ASN.V124814","article-title":"Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?","volume":"12","author":"Herzig","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/ndt\/gfl511","article-title":"Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients","volume":"22","author":"van Ree","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1432-2277.2007.00472.x","article-title":"A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients","volume":"20","author":"Winkelmayer","year":"2007","journal-title":"Transpl Int"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib18","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1053\/ajkd.2002.32794","article-title":"Pretransplant serum C-reactive protein and the risk of chronic allograft nephropathy in renal transplant recipients: a pilot case-control study","volume":"39","author":"Fink","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib19","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00007890-200003150-00034","article-title":"Pretransplant systemic inflammation and acute rejection after renal transplantation","volume":"69","author":"Perez","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/ndt\/18.1.147","article-title":"Regional variability in anaemia management and haemoglobin in the US","volume":"18","author":"Reddan","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib21","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1084\/jem.190.12.1733","article-title":"C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction","volume":"190","author":"Griselli","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1523-1755.2001.059002407.x","article-title":"End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?","volume":"59","author":"Arici","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00041552-200311000-00004","article-title":"Oxidative stress in uremia","volume":"12","author":"Himmelfarb","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib24","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1161\/01.ATV.0000084640.21712.9C","article-title":"Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease","volume":"23","author":"Brull","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib25","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/S0140-6736(05)67786-0","article-title":"C-reactive protein and its role in metabolic syndrome: mendelian randomisation study","volume":"366","author":"Timpson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib26","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1523-1755.2005.67135.x","article-title":"Elevated white cell count at commencement of peritoneal dialysis predicts overall and cardiac mortality","volume":"67","author":"Johnson","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib27","article-title":"Risk factors affecting nutritional status of dialysis patients: a quality improvement project","volume":"22","author":"Hopper","year":"2008","journal-title":"Nephrol News Issues"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib28","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/j.1600-6143.2004.00573.x","article-title":"Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.01.004_bib30","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N Engl J Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T04:17:23Z","timestamp":1634703443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915010000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0021915010000079"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.01.004","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}